Skip to content

Clinical trials

Completed Thromboembolism trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Status: Completed Country / region: Russia Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20071
20081
20092
20132
20143
20152
20161
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
Boehringer Ingelheim4
Astellas Pharma Inc2
Daiichi Sankyo2
Boston Scientific Corporation1
Bristol-Myers Squibb1
Janssen Research & Development, LLC1
Meshalkin Research Institute of Pathology of Circulation1
Ryazan State Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism17
Thrombosis6
Atrial Fibrillation5
Stroke5
Venous Thromboembolism4
Cardiovascular Diseases3
Embolism3
Pulmonary Embolism3
Venous Thrombosis3
Arrhythmias, Cardiac1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.